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Identification of a Mycobacterium tuberculosis-specific gene marker for diagnosis
of tuberculosis using semi-nested melt-MAMA qPCR (lprM-MAMA)
ABSTRACT
Tuberculosis (TB) is the deadliest of infectious diseases. TB diagnosis, based on sputum
microscopy, culture, and nucleic acid amplification tests (NAATs) to identify its main causative
agent, Mycobacterium tuberculosis (MTB), remains challenging. The current available NAATs,
endorsed by World Health Organization (WHO), can differentiate MTB from some MTB complex
(MTBC) members. Using bioinformatics, we identified a single nucleotide polymorphism (SNP)
in lprM (Rv1970) gene that differentiate MTB from other MTBC members. A forward mismatch
amplification mutation assay (MAMA) primer was designed for the targeted mutation and was
used in a semi-nested melt-MAMA qPCR (lprM-MAMA). Using the optimized protocol,
lprM-MAMA was positive with all MTB reference and clinical strains, and negative with other
MTBC members, non-tuberculous mycobacteria (NTM) and other non-mycobacterial (NM)
reference strains. The limit of detection (LOD) of lprM-MAMA was 76.29 fg. Xpert® MTB/RIF
(Xpert)-positive sputum samples were also positive by lprM-MAMA, except for samples
classified as having “very low” bacterial load by Xpert. Xpert-negative sputum samples were
also negative by lprM-MAMA. In conclusion, lprM-MAMA demonstrated to be a useful tool for
specific MTB diagnosis. Further evaluation with higher number of reference strains, including
NTM and NM; and sputum samples are required to determine its potential for clinical
application.
